STOCK TITAN

Lam Research director plans $3.0M stock sale

LAM RESEARCH CORP (LRCX) discloses a planned sale of its common stock under Rule 144 for the account of Bethany Mayer, a director, with the Jantzen/Mayer Family 2002 Trust as seller and Bethany Mayer as trustee.

(Neutral)
(Neutral)
Form Type
144

Rhea-AI Filing Summary

LAM RESEARCH CORP (LRCX) discloses a planned sale of its common stock under Rule 144 for the account of Bethany Mayer, a director, with the Jantzen/Mayer Family 2002 Trust as seller and Bethany Mayer as trustee. The notice covers 9,557 shares of common stock, with an aggregate market value of $3,007,970.18, planned for sale on September 9, 2026 through UBS Financial Services Inc. The shares relate to multiple prior RSU vesting events between October 31, 2021 and October 31, 2025.

Positive

  • None.

Negative

  • None.
Shares to be sold 9,557 shares Common Class A shares covered by the Rule 144 notice
Aggregate market value $3,007,970.18 Total market value of 9,557 LRCX shares to be sold
Planned sale date September 9, 2026 Date listed for sale of LRCX shares on NASDAQ
RSU vesting 2021 5,100 shares Common Class A acquired via RSU vest on October 31, 2021
RSU vesting 2023 5,630 shares Common Class A acquired via RSU vest on October 31, 2023
RSU vesting 2024 2,030 shares Common Class A acquired via RSU vest on October 31, 2024
RSU vesting 2025 1,622 shares Common Class A acquired via RSU vest on October 31, 2025
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
RSU VEST financial
"COMMON CLASS A | 10/31/2021 | RSU VEST | ISSUER"
attorney-in-fact regulatory
"as attorney-in-fact for BETHANY MAYER"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
Director other
"Director 144: Securities Information"
Trustee other
"BETHANY IS TRUSTEE ON THE TRUST."
A trustee is a person or institution legally appointed to hold and manage assets or enforce an agreement on behalf of other people (beneficiaries). Think of a trustee as a neutral referee or custodian who must act in the beneficiaries’ best interests, follow the trust or contract rules, and handle distributions, recordkeeping and enforcement. Investors care because a trustworthy trustee protects their rights, ensures promised payments or remedies are delivered, and can influence recoveries if things go wrong.

FAQ

What does the Form 144 filing disclose for LRCX?

The filing discloses a planned Rule 144 sale of 9,557 shares of LAM RESEARCH CORP common stock for an aggregate market value of $3,007,970.18, with a planned sale date of September 9, 2026 through UBS Financial Services Inc.

Who is selling the LRCX shares in this Form 144 notice?

The seller is the Jantzen/Mayer Family 2002 Trust. Bethany Mayer, a director of LAM RESEARCH CORP, is the trustee, and the notice is filed for her account, with UBS Financial Services Inc acting as attorney-in-fact for Bethany Mayer.

How many LRCX shares are planned to be sold and at what value?

The notice covers 9,557 shares of LRCX common stock with an aggregate market value of $3,007,970.18. These shares are to be sold on NASDAQ through UBS Financial Services Inc as indicated in the Form 144 filing.

What is the planned sale date for the LRCX shares in this Form 144?

The planned sale date for the 9,557 LRCX shares is September 9, 2026. The filing lists NASDAQ as the trading market and UBS Financial Services Inc as the broker handling the transaction.

How were the LRCX shares in this Form 144 acquired?

The filing links the shares to multiple RSU vesting events in LAM RESEARCH CORP common stock on October 31, 2021 (5,100 shares), October 31, 2023 (5,630 shares), October 31, 2024 (2,030 shares), and October 31, 2025 (1,622 shares), all from the issuer.

Were any LRCX shares sold by this seller in the past three months?

The Form 144 section for Securities Sold During The Past 3 Months does not report any transactions, indicating no LAM RESEARCH CORP shares by this seller are listed as sold in that recent period.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading